INT11364

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.58
First Reported 1992
Last Reported 2008
Negated 0
Speculated 3
Reported most in Abstract
Documents 4
Total Number 6
Disease Relevance 3.23
Pain Relevance 1.92

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (PLAU) signal transduction (PLAU) extracellular space (PLAU)
extracellular region (PLAU) plasma membrane (PLAU)
Anatomy Link Frequency
knee 6
PLAU (Homo sapiens)
Pain Link Frequency Relevance Heat
cINOD 11 100.00 Very High Very High Very High
Inflammation 4 100.00 Very High Very High Very High
metalloproteinase 9 98.48 Very High Very High Very High
Osteoarthritis 8 96.28 Very High Very High Very High
rheumatoid arthritis 5 92.96 High High
palliative 2 5.00 Very Low Very Low Very Low
methotrexate 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 11 100.00 Very High Very High Very High
Osteoarthritis 8 97.84 Very High Very High Very High
Cancer 29 96.60 Very High Very High Very High
Knee Osteoarthritis 3 96.48 Very High Very High Very High
Rheumatoid Arthritis 6 92.96 High High
Metastasis 13 92.92 High High
Recurrence 10 91.80 High High
Second Primary Neoplasms 1 90.80 High High
Death 1 85.60 High High
Breast Cancer 34 82.08 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
OBJECTIVES: The purpose of this study was to examine the ex vivo effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the expression of urokinase-type plasminogen activator (u-PA), PA inhibitor-1 (PAI-1) and gelatinases [matrix metalloproteinase (MMP)-2 and MMP-9] in the early knee osteoarthritis (OA) of humans.
Spec (examine) Regulation (effects) of Spec (examine) Gene_expression (expression) of u-PA in knee associated with inflammation, knee osteoarthritis, metalloproteinase, cinod and osteoarthritis
1) Confidence 0.58 Published 2008 Journal Clin. Biochem. Section Abstract Doc Link 17996201 Disease Relevance 0.35 Pain Relevance 0.47
For the univariate and multivariate analyses, we investigated the prognostic value of uPA and PAI-1 mRNA levels by using the median of expression generating "high" and "low" level groups.
Spec (investigated) Regulation (value) of Gene_expression (levels) of uPA
2) Confidence 0.44 Published 2006 Journal BMC Cancer Section Body Doc Link PMC1564186 Disease Relevance 0.95 Pain Relevance 0
The effect of indomethacin on uPA and uPAR expression in these cells was also examined.
Regulation (effect) of Gene_expression (expression) of uPA
3) Confidence 0.43 Published 2003 Journal Dig. Dis. Sci. Section Abstract Doc Link 14714609 Disease Relevance 0.50 Pain Relevance 0.10
Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
Regulation (Effects) of Gene_expression (expression) of urokinase plasminogen in knee associated with inflammation, cinod and osteoarthritis
4) Confidence 0.42 Published 2008 Journal Clin. Biochem. Section Title Doc Link 17996201 Disease Relevance 0.29 Pain Relevance 0.46
OBJECTIVES: The purpose of this study was to examine the ex vivo effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the expression of urokinase-type plasminogen activator (u-PA), PA inhibitor-1 (PAI-1) and gelatinases [matrix metalloproteinase (MMP)-2 and MMP-9] in the early knee osteoarthritis (OA) of humans.
Spec (examine) Regulation (effects) of Spec (examine) Gene_expression (expression) of urokinase-type plasminogen activator in knee associated with inflammation, knee osteoarthritis, metalloproteinase, cinod and osteoarthritis
5) Confidence 0.37 Published 2008 Journal Clin. Biochem. Section Abstract Doc Link 17996201 Disease Relevance 0.35 Pain Relevance 0.47
The effect of therapeutic and pharmacological concentrations of tiaprofenic acid, a non-steroidal anti-inflammatory drug (NSAID), on the synthesis of the plasminogen activators, urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA), and the plasminogen activator inhibitors 1 and 2 (PAI-1 and PAI-2), by human synovial membranes isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) sufferers was evaluated.
Regulation (effect) of Gene_expression (synthesis) of uPA associated with inflammation, rheumatoid arthritis, cinod and osteoarthritis
6) Confidence 0.29 Published 1992 Journal Br. J. Rheumatol. Section Abstract Doc Link 1555050 Disease Relevance 0.80 Pain Relevance 0.42

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox